In the midst of physician concerns that Part B drug reimbursements are too low, the Department of Health and Human Services' Office of Inspector General (OIG) is suggesting the Centers for Medicare ...

The current formula for Social Security's cost-of-living adjustments (COLA) is under scrutiny for failing to keep pace with ...

With the cancer drug market recently having hit US$100 billion, and some industry experts concerned that cancer drug prices are unsustainable, two groups have started working towards calculating the ...

It costs around US$880 million to bring a new drug to market, even when the price of failure and the cost of capital are included, suggests the latest stab at calculating the cost of drug development.